当前位置:首页 - 行情中心 - 南微医学(688029) - 财务分析 - 现金流量表

南微医学

(688029)

  

流通市值:157.42亿  总市值:157.42亿
流通股本:1.88亿   总股本:1.88亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,540,906,560.51,667,285,443.97844,007,963.33,334,176,666.2
  收到的税费返还35,231,490.2928,969,743.494,236,766.3112,255,560.13
  收到其他与经营活动有关的现金33,107,300.0120,130,742.6613,155,065.176,514,804.65
  经营活动现金流入小计2,609,245,350.81,716,385,930.12861,399,794.713,422,947,030.98
  购买商品、接受劳务支付的现金929,462,371.67627,132,294.32350,387,852.431,201,136,680.78
  支付给职工以及为职工支付的现金670,109,423.69477,417,226.89282,280,371.85795,544,556.02
  支付的各项税费146,495,732.7398,948,542.2736,985,662.63212,145,329.7
  支付其他与经营活动有关的现金394,100,876.65262,925,614.3985,343,129.1526,174,710.85
  经营活动现金流出小计2,140,168,404.741,466,423,677.87754,997,016.012,735,001,277.35
  经营活动产生的现金流量净额469,076,946.06249,962,252.25106,402,778.7687,945,753.63
二、投资活动产生的现金流量:
  收回投资收到的现金9,645,717,108.665,186,396,528.992,474,981,569.981,527,310,151.52
  取得投资收益收到的现金23,905,596.3812,475,010.047,453,797.3434,625,622.19
  处置固定资产、无形资产和其他长期资产收回的现金净额551,274.2265,102.84692.843,702,004.03
  收到的其他与投资活动有关的现金---60,592,477.7
  投资活动现金流入小计9,670,173,979.265,198,936,641.872,482,436,060.161,626,230,255.44
  购建固定资产、无形资产和其他长期资产支付的现金133,577,746.13113,579,182.08107,452,938.68254,930,231.13
  投资支付的现金9,510,960,682.495,286,968,300.542,756,282,760.812,056,029,942.17
  取得子公司及其他营业单位支付的现金---240,280,432.95
  投资活动现金流出小计9,644,538,428.625,400,547,482.622,863,735,699.492,551,240,606.25
  投资活动产生的现金流量净额25,635,550.64-201,610,840.75-381,299,639.33-925,010,350.81
三、筹资活动产生的现金流量:
  吸收投资收到的现金5,027,781.85,027,781.85,027,781.88,000,002.8
  其中:子公司吸收少数股东投资收到的现金5,027,781.85,027,781.85,027,781.88,000,002.8
  取得借款收到的现金200,000,000200,000,000-190,000,000
  筹资活动现金流入小计205,027,781.8205,027,781.85,027,781.8198,000,002.8
  偿还债务支付的现金190,442,003.27190,352,462.75191,227,752.0673,517,413.77
  分配股利、利润或偿付利息支付的现金201,119,192.67186,896,688.16229,534.72282,297,811.94
  其中:子公司支付给少数股东的股利、利润11,280,218.59---
  支付其他与筹资活动有关的现金14,136,061.310,189,6533,393,912.4446,012,992.25
  筹资活动现金流出小计405,697,257.24387,438,803.91194,851,199.22401,828,217.96
  筹资活动产生的现金流量净额-200,669,475.44-182,411,022.11-189,823,417.42-203,828,215.16
四、汇率变动对现金及现金等价物的影响-96,060,593.65-74,043,735.23-41,618,903.547,352,730.89
五、现金及现金等价物净增加额197,982,427.61-208,103,345.84-506,339,181.59-433,540,081.45
  加:期初现金及现金等价物余额1,436,676,056.751,436,676,056.751,436,676,056.751,870,216,138.2
  期末现金及现金等价物余额1,634,658,484.361,228,572,710.91930,336,875.161,436,676,056.75
补充资料:
  净利润-308,468,034.18-582,557,650.02
  资产减值准备-10,803,100.29-42,513,477.38
  固定资产和投资性房地产折旧-35,946,270.69-68,835,313.4
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-35,946,270.69-68,835,313.4
  无形资产摊销-19,158,100.09-36,595,161.58
  长期待摊费用摊销-9,665,708.67-19,867,459.75
  处置固定资产、无形资产和其他长期资产的损失--41,173.8--103,715.12
  固定资产报废损失-442,440.35-444,186.47
  公允价值变动损失--975,595.22--928,013.63
  财务费用-78,875,451.24--18,591,035.1
  投资损失--7,610,395.57--16,942,047.43
  递延所得税--6,651,801.34--7,964,000.27
  其中:递延所得税资产减少--2,914,427.82--6,966,876.09
    递延所得税负债增加--3,737,373.52--997,124.18
  存货的减少--20,309,281.33--54,279,029.92
  经营性应收项目的减少--43,422,380.38-16,354,183.31
  经营性应付项目的增加--152,554,297.8--10,562,073.84
  其他-1,881,570.83--
  现金的期末余额-1,228,572,710.91-1,436,676,056.75
  减:现金的期初余额-1,436,676,056.75-1,870,216,138.2
  现金及现金等价物的净增加额--208,103,345.84--433,540,081.45
公告日期2026-10-302026-08-272026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑